OverviewChartNewsTraderScreen

BNP Paribas Call 115 AZN 20.12.20.../  DE000PC3BU17  /

EUWAX
2024-06-04  3:37:41 PM Chg.+0.22 Bid10:00:37 PM Ask10:00:37 PM Underlying Strike price Expiration date Option type
1.86EUR +13.41% -
Bid Size: -		 -
Ask Size: -		 Astrazeneca PLC ORD ... 115.00 GBP 2024-12-20 Call
GlobeNewswire 06-04 Nordicus Partners Corporation Appoints Peter Severin as Chairman Of The Board of Directors
GlobeNewswire 06-04 Quell Therapeutics Advances QEL-001, its Multi-modular Engineered CAR-Treg Cell Therapy, into Effica...
GlobeNewswire 06-04 CytoSorbents STAR Registry Data on Patients on Ticagrelor Undergoing CABG Surgery with CytoSorb Pres...
GlobeNewswire 05-28 Cellectis Reports Financial Results for First Quarter 2024
TeleTrader 05-21 AstraZeneca to deliver $80B total revenue by 2030
TeleTrader 05-20 AstraZeneca to build $1.5B plant in Singapore
GlobeNewswire 05-08 Annual NMDP Gala in New York Raises More Than $560,000, Enabling More Patients to Receive Life-Savin...
GlobeNewswire 05-06 FibroGen Reports First Quarter 2024 Financial Results
GlobeNewswire 05-06 Cellectis Announces Completion of the Additional Equity Investment by AstraZeneca
GlobeNewswire 05-02 Press Release: Beyfortus real-world evidence published in The Lancet shows 82% reduction in infant R...
GlobeNewswire 04-29 Cellectis Reports Financial Results for the Fourth Quarter and Full Year 2023
TeleTrader 04-25 Europe opens mostly down after corporate earnings
TeleTrader 04-25 AstraZeneca Q1 revenue jumps 19% to $12.7B
GlobeNewswire 03-28 HUTCHMED Announces Savolitinib sNDA Accepted in China for Treatment-Naïve or Previously Treated Pati...
TeleTrader 03-19 AstraZeneca to acquire Fusion for $2 billion
GlobeNewswire 03-18 AAFA Statement in Response to AstraZeneca Asthma Inhaler Cost Announcement
TeleTrader 03-14 AstraZeneca to acquire Amolyt Pharma for $1.05B
GlobeNewswire 03-14 Amolyt Pharma Enters into Definitive Agreement to be Acquired by AstraZeneca
GlobeNewswire 02-28 HUTCHMED Reports 2023 Full Year Results and Provides Business Updates
GlobeNewswire 02-26 FibroGen Reports Fourth Quarter and Full Year 2023 Financial Results
GlobeNewswire 02-26 FibroGen Regains All Rights to Roxadustat from AstraZeneca in the United States and Other AstraZenec...
GlobeNewswire 02-22 Gracell Biotechnologies Acquisition Completed
GlobeNewswire 02-22 Sodexo and AstraZeneca extend their global partnership for a further 5 years.
GlobeNewswire 02-20 Gracell Biotechnologies Announces Shareholders’ Approval of Merger Agreement
TeleTrader 02-09 Europe mostly lower premarket amid German CPI, earnings